Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 4Cancer Pain 4Neoplasms 3Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Signs and Symptoms 1Postoperative Complications 1Pathologic Processes 1Pain, Postoperative 1Pain Related to Cancer 1Neurologic Manifestations 1Neuralgia 1Head and Neck Neoplasms 1Chronic Pain 1Breakthrough Pain 1

Interventions

relacorilant 1pembrolizumab 1glutathione pegylated liposomal doxorubicin 1ficlatuzumab 1bosutinib 1Trastuzumab 1Pemetrexed 1Morphine 1Methadone 1MRX-2843 1Imatinib Mesylate 1Cholecalciferol 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pathologic Processes × Methadone × Clear all
NCT04475029 2023-09-13

METAMORF

University of Aarhus

Phase NA Completed
114 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neurologic Manifestations, Pain, Pain, Postoperative, Pathologic Processes, Postoperative Complications, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡